Home
overview

For the latest COVID-19 Travel restrictions and recommendations please click here

SAE Media Group’s 4th Annual Conference
Injectable Drug Delivery 
11 - 12 May, 2022 | St James' Court, London, UK
-------------------------------------------------------------------------
As Part of Europe’s leading Injectable conference series, we will assess innovations in drug product formulation and biologics, new technologies in device design and the use of long-release injectable compounds.


There is a rising demand for vaccines, insulin,  and many modern medicines used to treat cancer and other chronic diseases. As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drug delivery and prefilled syringe market in the coming years. The injectable drug delivery market is expected to rise at a compound annual growth rate of 12.9% reaching £915 billion by 2027.


This year’s event will highlight innovations within the industry with regard to injectable device design and the formulation challenges of long-lasting, highly viscous and high volume drug delivery. There will be an additional focus on the impact that covid has had on advances within this industry over the past year. The conference will also highlight the significance of sustainability within the injectable drug delivery industry, whilst providing regulatory insight on the changes that have occurred.

  • Discover the new technologies and latest injectable devices being used within the industry 
  • Develop your understanding of high-volume and long-acting injectable compounds 
  • Explore the sustainable possibilities that can be adapted within the industry for a green future
  • Delve into the world of biologics and biosimilars and what these mean for the injectable drug market 
  • Network with key industry leaders and discover the leading companies within the injectables space
     

Advanz Pharma; AstraZeneca; Bayer AG; Boehringer Ingelheim GmbH; Boehringer Ingelheim Pharma AG; Boehringer Ingelheim Pharma GmbH & Co. KG; BSI Group; Chiesi Ltd; EVEON; Gerresheimer; GlaxoSmithKline; GSK; IPSEN Pharmsciences; Janssen Pharmaceutical Companies; MedinCell; MHRA; Midas Pharma Gmbh; Midatech Pharma; Noble International Inc.; Novartis; Owen Mumford Ltd; PDM solutions; Pfizer; PHC Corporation; Sabic; SI02 Medical Products ; Stevanato Group S.P.A.; Stewart Urquhart consulting Ltd; Sustainable Healthcare Coalition; Team Consulting Limited; Telstar; Teva; TUV SUD Japan Ltd.; Tyndall National Institute; University of Southern Denmark; Vetter Pharma International GmbH; Vetter Pharma-Fertigung GmbH & Co. KG; Victrex Plc; Viridian Therapeutics;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Rene Holm

Rene Holm, Professor, University of Southern Denmark
View Bio

9:10 Unpacking Impact of EU MDR Requirements on the Risk Management Process for Drug-Device Combination Products

Fatima Bennai-Sanfourche

Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG

  • Regulatory landscape changes
  • EU MDR article 117 -Requirements
  • Requirements on device risk management process
  • Impact of the EU MDR on drug-device risk management process
  • Usability engineering/Human Factors (HF)
     
  • 9:50 Notified Body Expert Insight: The EU MDR one year on

    Julia Frese

    Julia Frese, Director, TUV SUD Japan Ltd.
    View Bio

  • Insights into notified body and industry experiences further to the EU MDR implementation
  • What are the main challenges that we have seen and how can industry work alongside Notified Bodies going forward?
  • Team-NB updates and insights on the injectable delivery regulatory environment
  • Looking to the future: Now that the EU MDR has been implemented where are the gaps in guidance and what is needed next?
     
  • 10:30 Morning Coffee

    11:00 Control of N-Nitrosamine Impurities in Human Drugs

    David Deutsch

    David Deutsch, Leading Senior Pharmaceutical Assessor, MHRA

  • What are nitrosamine impurities and why do we need daily limits?
  • Recalling of drugs by the manufacturer as recommended by regulatory bodies
  • Understanding the updated guidance on nitrosamines, what’s changed and what do industry need to consider?
  • Testing methods to detect nitrosamine impurities
  • Sources of the impurities and how they can be avoided
     
  • 11:40 Injectable Long-Lasting Antipsychotic drugs for the treatment of Schizophrenia

    Rene Holm

    Rene Holm, Professor, University of Southern Denmark
    View Bio

  • How do long-lasting antipsychotics work within the body over time
  • Key considerations for long lasting injectable drug formulations
  • Altering the drug formulations for better treatment of schizophrenia
  • The benefit to patients of having long-last treatment for schizophrenia
  • 12:20 Networking Lunch

    13:20 Overview of Development and Regulatory Landscape for On-Body Delivery Systems

    Prashant Bhatia

    Prashant Bhatia, Associate Director, AstraZeneca

  • Increase in demand for novel large-volume drug delivery devices
  • Development considerations for on-body injectors
  • Global overview on regulatory pathway for OBIs
  • Challenges for the industry with large-volume delivery devices
  • 14:00 Development of secondary packaging for combination products with an end-to-end thinking

    Cristiana Heese

    Cristiana Heese, Packaging Engineer Combination Products, Boehringer Ingelheim Pharma Gmbh & Co. Kg

  • What are the challenges in the development of secondary packaging for combination products?
  • Development process is an iterative, collaborative and user-driven approach with an end-to-end thinking
  • Success factor for development and technical transfer of secondary packaging
  • Learnings and best practice from secondary packaging development projects
  • 14:40 Afternoon Tea

    15:10 Solving drug delivery device challenges with high performance polymers

    Marcus Jarman-Smith

    Marcus Jarman-Smith, Strategic Marketing Manager and New Business Development, Victrex Plc
    View Bio

  • Traditional materials, such as commodity polymers and metals, can be used for some applications, but what happens when there are multiple engineering requirements for components that have complex designs and need to operate with precision over a long lifetime?
  • Increasingly, designers are looking to high-performance polymers for answers. Without a doubt, poly-ether-ether-ketone (PEEK) is one of the highest performing polymers, and one that can support multiple engineering requirements including weight, space optimisation, thermal environments and complex miniaturised electronic components.
  • Dr Jarman-Smith will present concept designs for next generation drug delivery devices with complex engineering requirements, including a smart, wearable injectable patch pump with the electronics are sintered directly into a PEEK polymer casing to create an antenna to communicate wirelessly via Bluetooth.
     
  • 15:50 Patient-focused drug-delivery solutions for subcutaneous injection of large molecule biologics

    Reza Abedian

    Reza Abedian, Senior Medical Affairs Manager, Gerresheimer
    View Bio

  • Subcutaneous drug delivery
  • Large molecules (biologics)
  • Customized on-body devices
  • Autoinjector
     
  • 16:30 Chairman's Closing Remarks and Close of Day One

    Rene Holm

    Rene Holm, Professor, University of Southern Denmark
    View Bio

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Joel Richard

    Joel Richard, Chief Scientific Officer, MedinCell
    View Bio

    9:10 Long Acting Injectable Formulations of Fragile Drugs: Challenges and Opportunities for New Delivery Technologies

  • The benefit of long-acting injectable formulations of fragile drugs for patients
  • Specific challenges for formulation of fragile drugs (peptides and proteins): short half-life, poor chemical stability, aggregation propensity, etc…
  • Successful technologies for long acting injectables and their limitations
  • Competitive advantages of new technologies based on injectable in situ forming implants
  • Case studies: recent progress in BEPO long acting injectable formulation development of peptides and proteins.
     
  • Joel Richard

    Joel Richard, Chief Scientific Officer, MedinCell
    View Bio

    9:50 Polymer vials - An alternative to glass for parenteral drugs?

  • Difference between materials - glass and polymer
  • Challenges for drug stability and safety: permeation behaviour and differences regarding their break resistance
  • Points to consider in selecting polymer vials
  • Friederike Ruebeling

    Friederike Ruebeling, Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG
    View Bio

    10:30 Morning Coffee

    11:00 Development of Medical Devices: A Toxicologists Perspective

    Clemens Gunther

    Clemens Gunther, Director, Senior Expert Nonclinical Safety, Bayer AG
    View Bio

  • Mastering the biocompatibility program
  • How to comply with requirements on Extractable & Leachable testing
  • Strategies to generate the Toxicological Risk Assessment
  • 11:40 Combination products & device delivery platforms: A winning team?

  • Device platform development for combination products: Opportunities and challenges
  • Key takeaways of a marketed inhalation device platform and how this can be applied to injectable devices
  • Fast to clinic: A (DHF) Platform Approach for PFS in clinical trials and beyond
  • Outlook Key considerations for developing successful injectable delivery platforms
  • Sabine Kattenbeck

    Sabine Kattenbeck, Head Device Project Management, Boehringer Ingelheim Pharma GmbH & Co. KG
    View Bio

    Gabriele Widerstein

    Gabriele Widerstein, Device Lead, Boehringer Ingelheim GmbH
    View Bio

    12:20 Networking Lunch

    13:20 Key design considerations for an emergency-use injection system

    John Burke

    John Burke, Senior Industrial Design Consultant, Team Consulting Limited
    View Bio

  • How to optimize user experience: the design and usability challenges of an emergency-use device
  • Achieving five nines reliability
  • Sustainability choices in your development
     
  • 14:00 Case Study: An insight into Chiesi’s UK take-back pilot

    Aaron Gowson

    Aaron Gowson, Public Affairs Manager, Chiesi Ltd

  • Understanding current challenges in inhaler disposal and sustainability
  • An exploration into Chiesi’s pilot scheme for efficient inhaler recycling
  • Key takeaways from the pilot and assessing user feedback
  • Looking to the future, how can the learnings from this pilot be applied to enhancing sustainability throughout the drug delivery device industry

     

  • 14:40 Afternoon Tea

    15:10 The power of collaboration to deliver sustainable healthcare

    Fiona Adshead

    Fiona Adshead, Chair, Sustainable Healthcare Coalition
    View Bio

  • The presentation will outline how the Sustainable Healthcare Coalition, a partnership of leading companies and public sector agencies, addresses some of the most pressing sustainability issues in global healthcare.
  • Case studies of digital approaches and connected devices will demonstrate how healthcare sector industry partners can help the NHS achieve NetZero and bring together clinicians and industry to meet the challenges of improving sustainability through innovation.
     
  • 15:50 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Aaron Gowson

    Aaron Gowson

    Public Affairs Manager, Chiesi Ltd
    Clemens Gunther

    Clemens Gunther

    Director, Senior Expert Nonclinical Safety, Bayer AG
    Cristiana Heese

    Cristiana Heese

    Packaging Engineer Combination Products, Boehringer Ingelheim Pharma Gmbh & Co. Kg
    David Deutsch

    David Deutsch

    Leading Senior Pharmaceutical Assessor, MHRA
    Fatima Bennai-Sanfourche

    Fatima Bennai-Sanfourche

    Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG
    Fiona Adshead

    Fiona Adshead

    Chair, Sustainable Healthcare Coalition
    Friederike Ruebeling

    Friederike Ruebeling

    Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG
    Gabriele Widerstein

    Gabriele Widerstein

    Device Lead, Boehringer Ingelheim GmbH
    Joel Richard

    Joel Richard

    Chief Scientific Officer, MedinCell
    John Burke

    John Burke

    Senior Industrial Design Consultant, Team Consulting Limited
    Julia Frese

    Julia Frese

    Director, TUV SUD Japan Ltd.
    Marcus Jarman-Smith

    Marcus Jarman-Smith

    Strategic Marketing Manager and New Business Development, Victrex Plc
    Prashant Bhatia

    Prashant Bhatia

    Associate Director, AstraZeneca
    Rene Holm

    Rene Holm

    Professor, University of Southern Denmark
    Reza Abedian

    Reza Abedian

    Senior Medical Affairs Manager, Gerresheimer
    Sabine Kattenbeck

    Sabine Kattenbeck

    Head Device Project Management, Boehringer Ingelheim Pharma GmbH & Co. KG

    Aaron Gowson

    Public Affairs Manager, Chiesi Ltd
    Aaron Gowson

    Clemens Gunther

    Director, Senior Expert Nonclinical Safety, Bayer AG
    Clemens Gunther

    Dr. Clemens Günther received his diploma in biology and doctorate for natural sciences from the Free University, Berlin-Germany. He started his professional career in 1990 at Schering AG, Berlin-Germany. From 2007 to 2013, Dr. Clemens Günther was Director and Head of Global Preclinical Development at Intendis GmbH, branded later-on as Bayer Dermatology. After integration of Intendis into Bayer in 2013, he became Director Nonclinical Safety Consumer Care and later-on Senior Expert Nonclinical Safety within the Division of Bayer Pharmaceuticals. Meanwhile Dr. Clemens Günther has gained over 30 years experience in drug development. He has been involved in nonclinical development and regulatory toxicology of small molecules, biologics, medical devices and drug device combination products in various medical indications.
     

    Cristiana Heese

    Packaging Engineer Combination Products, Boehringer Ingelheim Pharma Gmbh & Co. Kg
    Cristiana Heese

    David Deutsch

    Leading Senior Pharmaceutical Assessor, MHRA
    David Deutsch

    Fatima Bennai-Sanfourche

    Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG
    Fatima Bennai-Sanfourche

    Fiona Adshead

    Chair, Sustainable Healthcare Coalition
    Fiona Adshead

    Fiona chairs the Sustainable Healthcare Coalition that inspires partnerships and action on sustainable healthcare. She also works as an independent expert advisor and board member for national and global organisations on wellbeing and sustainability.

    She is a high-profile wellbeing and public health leader with a track record of reframing thinking and developing innovative strategy and programmes at the heart of business and government. Her previous roles include Deputy Chief Medical Officer and Director General in the UK Government, Director of Chronic Disease and Health Promotion at the World Health Organisation and Bupa’s Chief Wellbeing Officer.

    Fiona is a visiting Professor at UCL and teaches at Cambridge Institute for Sustainability Leadership. Fiona’s recent board roles include British Land’s Sustainability Advisory Panel, Marks and Spencer’s Sustainable Retail Advisory Board, and Business in the Community’s Wellbeing Leadership Team.


     

    Friederike Ruebeling

    Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG
    Friederike Ruebeling

    Dr. Friederike Ruebeling studied chemical and process engineering at the university in Karlsruhe (Karlsruhe Institute of Technology, KIT), where she also wrote her PhD thesis about the microstructure evolution in copper due to tribological loading. After her PhD, she started working at Boehringer Ingelheim Pharma GmbH & Co. KG as a Postdoc. Now in a scientist position within the Primary Packaging and Process Development group, she investigates the suitability of various primary packaging materials with a particular focus on vials and pre-fillable syringes.

    Gabriele Widerstein

    Device Lead, Boehringer Ingelheim GmbH
    Gabriele Widerstein

    Gabriele Widerstein is a chemical engineer by education and 20+ years of industrial experience with a strong focus on Project Management as well as Quality & Regulatory Compliance in various fields of pharma industry (esp. in development & lifecycle management of medical devices and combination products).
    Since 2019 she leads project teams for the development of devices/combination products.
    Prior to this role she provided project specific and overarching quality and regulatory input and guidance at Sanofi to develop devices and combination products for submission and throughout end of lifecycle.
     

    Joel Richard

    Chief Scientific Officer, MedinCell
    Joel Richard

    Dr Joël Richard is currently Chief Scientific Officer (CSO) at MedinCell (Montpellier, France). He is leading the Research activities and the Pre-Clinical Drug Development activities of the company, based on the proprietary technology BEPO® for Long-Acting Injectables. (LAIs). These activities comprise Research activities on new biomaterials and drug delivery technologies, CMC and Non-Clinical activities, supply of clinical batches, and quality and regulatory compliance. Dr Richard has more than 30 years of experience in chemistry and (bio)pharmaceutical R&D, including several global senior leadership positions in various Biotech and Pharma companies, such as Ipsen (France), Serono (Italy), MerckSerono (Germany), Ethypharm (France). Dr Richard has focused his research activity on new formulation technologies and innovative drug delivery systems (microspheres, nanosystems, self-assembling gels), especially for injectable peptide and protein formulations. He has graduated from Ecole Normale Supérieure (Cachan, France) and got a PhD in Materials Science (Paris VI, France). He has published 72 peer-reviewed scientific papers, 8 book chapters and 2 review editorials in various fields. He is the author of 140 international communications and 55 patent families. He has also been serving as an APGI Board Member for 3 years and is a Member of the Controlled Release Society (CRS).

    John Burke

    Senior Industrial Design Consultant, Team Consulting Limited
    John Burke

    John specialises in the design and project management of medical devices, with a particular focus on the development of parenteral drug delivery devices. A designer by training with a strong grounding in medical design and regulatory focused human factors, he regularly attends user studies in both Europe and the US.
    John brings experience of both consumer and medical product development, having worked on a diverse range of products, including drug delivery devices, wound management, diagnostics platforms and blood glucose monitoring. He has a degree in Product Design from Nottingham Trent University and has worked in design consultancy roles in London and Cambridge.
     

    Julia Frese

    Director, TUV SUD Japan Ltd.
    Julia Frese

    By education biomedical engineer with a Master degree in business administration. Julia gained experience in development, regulatory approval of combination devices and ATMP products. She was further involved in the development of standards for ATMP products. Currently Julia Frese is heading the division of Medical and Health Services at TÜV SÜD Japan and is responsible for the development of article 117 service within the organisation. She is further co-chair of the Team NB working group for article 117.

    Marcus Jarman-Smith

    Strategic Marketing Manager and New Business Development, Victrex Plc
    Marcus Jarman-Smith

    Marcus joined Victrex in 2006 and has held technical roles with Victrex's medical business unit (Invibio) and commercial roles, most recently in Business Development, scouting for breakthrough technologies as well as supporting the development of Victrex's Additive Manufacturing offering. Marcus holds a PhD in chemical engineering, tissue engineering and biomaterials from the University of Bath, in the UK. Marcus's expertise is in PEEK in medical and dental applications as well as food contact, materials and technologies for Additive Manufacturing and 3D printing.

    Prashant Bhatia

    Associate Director, AstraZeneca
    Prashant Bhatia

    Rene Holm

    Professor, University of Southern Denmark
    Rene Holm

    René Holm received his pharmaceutical training at the Royal Danish School of Pharmacy, now the school of pharmacy at University of Copenhagen, Denmark, in 1998 and his PhD in biopharmaceutics from the same institution in 2002. Dr. Holm joined Lundbeck in 2001 and changed to Janssen in 2016. Dr. Holm has worked within pharmaceutical development, formulations for non-clinical testing in drug discovery, physical chemistry and material science covering both small and large molecules and is now responsible for the functional unit ensuring development of all non-solid formulations for Janssens small molecule value stream.

    Dr. Holm is (co-) author of more than 185 original articles in peer-reviewed journals and patents in the field of biopharmaceutics, preformulation, formulation and physical pharmacy and is a honorary professor in physical chemistry at the Department of Science and Environment, University of Roskilde, Denmark.


     

    Reza Abedian

    Senior Medical Affairs Manager, Gerresheimer
    Reza Abedian

    Currently working as Senior Medical Affairs Manager with Gerresheimer companies. He specializes in medical affairs and clinical research, supporting value-based product development with strong focus on patient centricity. He holds a PhD in musculoskeletal biomechanics and tissue engineering from Hannover Medical School, Laboratory for biomechanics and biomaterials. He has supported several product development/launches and market authorization of medical devices under FDA, MDD/MDR and other global market requirements, during the past 10 years while having worked in multiple sectors of the medical device and pharma industry.

    Sabine Kattenbeck

    Head Device Project Management, Boehringer Ingelheim Pharma GmbH & Co. KG
    Sabine Kattenbeck

    Sabine Kattenbeck is heading the device project management group at Boehringer Ingelheim, with many years’ experience in drug regulatory affairs and medical devices. She gained major expertise in medical device development and global market introduction of a device/ combination product platform, leading crossfunctional teams from Start of Development to Launch.

    Sponsors

    Exhibitors

    Supporters

    VENUE

    St James' Court

    Buckingham Gate, London, United Kingdom

    In a country that values understatement, St. James' Court is an English classic typifying the concealed charm of one of Britain's finest hotels. With a distinguished pedigree shaped over more than a century, this discreet masterpiece offers elegant service, with an easy charm that’s reserved, yet attentive. Exceeding the expectations of today’s discerning traveller, St. James' Court is a slice of the past served up on a contemporary platter.

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SAE Media Group. SAE Media Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Speaker Interview - Rebecca Moses & Kim Alexander, Core Human Factors

    Download

    Speaker Interview - Prashant Bhatia, AstraZeneca

    Download

    Past Attendees

    Download

    Conference Co-Chair Letter

    Download

    Workshop B Agenda

    Download

    Workshop A Agenda

    Download

    Speaker Interview - Fatima Bennai-Sanfourche, Bayer AG

    Download

    Speaker Biographies

    Download

    Survey Results Infographic - State of the Industry 2022

    Download

    Injectable Drug Delivery Brochure 2022

    Download

    Survey Results

    Download

    Past Presentation: Mark Palmer, GSK

    Download

    Past Presentation: Jonathan Sutch, BSI

    Download

    Past Presentation: Christian Dechant, Boehringer Ingelheim

    Download

    Past Presentation: Blake Green, Amgen

    Download

    Past Presentation: Amanda Matthews, Pfizer

    Download

    Sponsors


    Gerresheimer

    Sponsors
    http://www.gerresheimer.com

    Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 10,000 employees and generates annual sales of more than €1.4 billion. With its products and solutions, Gerresheimer plays an essential role in people's health and well-being.


    Victrex

    Sponsors
    http://www.victrex.com

    Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of automotive, aerospace, energy (including manufacturing & engineering), electronics and medical. Every day, millions of people use products and applications which contain our sustainable materials – from smartphones, aeroplanes and cars to oil and gas operations and medical devices. With over 40 years’ experience, we develop world leading solutions in PEEK and PAEK based polymers, semi-finished and finished parts which shape future performance for our customers and our markets, provide environmental and societal benefits, and drive value for our shareholders. Find out more at www.victrex.com

    Exhibitors


    Owen Mumford

    Exhibitors
    http://www.owenmumford.com

    Owen Mumford Pharmaceutical Services is a specialist in the design, development and manufacture of injectable drug delivery systems for the pharmaceutical, biotech & generics industries. These include single dose and multidose reusable and disposable auto-injectors, pens and syringes for subcutaneous and intramuscular administration. Our innovative products are designed to meet both the need of our pharmaceutical partners and their patients by facilitating ease of use and improving safety and patient compliance. Our devices are also designed with aim of reducing complexity and risk for the pharmaceutical & biotech industry in the development of their combination products.

    For more information please visit https://www.ompharmaservices.com/



    PHC Group

    Exhibitors
    http://

    The PHC Group provides products and services for diabetes management, life sciences and diagnostics, as well as enhanced healthcare solutions that are used by patients, healthcare professionals and researchers in over 125 countries. By integrating digital solutions with our expertise in precision technology that has been nurtured over decades, we provide the best-in-class devices and services for advancing basic research, diagnosis and medical treatment.

    Media Partners


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    pharmanews hq

    Supporters
    http://http://pharmanewshq.com

    MedChemNet provides a unique and unparalleled platform for the medicinal chemistry community to share insights, discuss the latest research, and help move the field forward. MedChemNet covers all aspects of the drug discovery pipeline, from target identification and validation, through computer aided drug design (CADD), synthesis, screening and other biophysical techniques, to development of novel lead compounds and pre-clinical in vivo proof of concept. We also cover the design of synthetic drug delivery carriers and ADME/toxicology studies, as well as intellectual property and economic related issues. Website: Welcome to Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production.


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    ASD MEDIA

    Supporters
    http://www.asd-network.com

    Professionals in the Aerospace & Defence market use the ASD Media internet platforms to:
    • Be informed on the latest market developments; www.asd-network.com
    • Find the latest business news; www.asd-network.com
    • Find the upcoming events; www.asd-network.com
    • Find companies and organizations; www.asdsource.com
    • Distribute news globally. www.asdwire.com
    The ASD Media platforms are well known and used intensively, your company is able to benefit from these large numbers of users. Be informed with ASD-Network; Create exposure for your company with ASDSource, distribute your news with ASDWire or advertise with us, build your brand and increase traffic to your company’s website.

    For more detailed information please contact with: ASD MEDIA
    Stefan.koopman@asdmedia.nl


    Gene Therapy Net

    Supporters
    http://www.genetherapynet.com

    Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines


    ONdrugDelivery Magazine

    Supporters
    http://ondrugdelivery.com

    ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: www.ondrugdelivery.com/subscribe.


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    World Pharma News

    Supporters
    http://www.worldpharmanews.com/



    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    World Pharma Today

    Supporters
    http://www.worldpharmatoday.com



    evvnt Ltd

    Supporters
    http://www.evvnt.com

    evvnt enables people all over the world to fill their events utilising the most effective event listing sites on the web. Every minute, with little more than a click, more events and conferences appear in listings, in search engines and on mobile - discoverable by both category and location. With next to no effort customers of evvnt get better attendance, while consumers find events they previously had no idea existed. To date customers in 70 countries worldwide have submitted over 500,000 thousand event listings, created over 300,000 live links, and generated 1 million clicks to ticketing and registration pages. Learn more at www.evvnt.com


    Pharma Journalist

    Supporters
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    St James' Court

    Buckingham Gate
    London SW1E 6AF
    United Kingdom

    St James' Court

    In a country that values understatement, St. James' Court is an English classic typifying the concealed charm of one of Britain's finest hotels. With a distinguished pedigree shaped over more than a century, this discreet masterpiece offers elegant service, with an easy charm that’s reserved, yet attentive. Exceeding the expectations of today’s discerning traveller, St. James' Court is a slice of the past served up on a contemporary platter.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out